AnodyneWiki

Lidocaine

Lidocaine
Lidocaine
Salts
[]
Lidocaine bicarbonate
Lidocaine bicarbonate
Lidocaine dicarbonate
Lidocaine dicarbonate
Lidocaine hydrochloride
Lidocaine hydrochloride
Lidocaine maleate
Lidocaine maleate
Lidocaine tosylate
Lidocaine tosylate
Lidocaine iminodiacetic acid
Lidocaine iminodiacetic acid
Lidocaine sulfate
Lidocaine sulfate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass234.34 g/mol [1]
AppearanceNeedles from benzene or alcohol [1]
OdorCharacteristic odor [1]
Melting point68.5 °C [1]
Boiling point159-160 °C at 2.00E+00 mm Hg [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1]
Solubility4100 mg/L (at 30 °C) [1]
Predicted LogP2.3 [1]
Structural Identifiers
[]
Molecular formulaC14H22N2O
IUPAC name2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
SMILESCCN(CC)CC(=O)NC1=C(C=CC=C1C)C
InChIInChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)
InChIKeyNNJVILVZKWQKPM-UHFFFAOYSA-N
CAS number137-58-6
UNII98PI200987
PubChem CID3676
Pharmacokinetics[]
OnsetWithin 1.5 min (IV)
Elimination half-life1.5 h–2 h
Duration of action10 min–20 min (IV), 0.5 h–3 h (local)
MetabolismLiver, 90% CYP3A4-mediated
ExcretionKidney
Routes of administrationIntravenous, subcutaneous, topical, by mouth
Toxicity
[]
Mouse:
- oral: 292 mg/kg
- ip: 105 mg/kg
- iv: 19.5 mg/kg
Non-Fasted Female Rats:
- 346-773) mg/kg (oral: 459
Rat:
- oral: 317 mg/kg
 [1]

Lidocaine (also known as Xylocaine, Esracaine, Xylestesin, Duncaine, Lidoderm, Gravocain, Isicaina, Leostesin, Maricaine or Solcain) is a anaesthetic, depressant and sodium channel blocker substance of the aniline class.

Chemistry

Salts []

Lidocaine is typically found in the form of its bicarbonate, dicarbonate, hydrochloride, maleate, tosylate, iminodiacetic acid and sulfate salts.

 []

Lidocaine is achiral.

Lidocaine matches Lipinski's rule of five.

There are currently 10 reagent-interactions on

ReagentColor changeDescription
Marquisfizzes clear
Meckeyellow
Mandelinbrown
Liebermannred
Froehdeno color change
Simon'sno blue color change
Ehrlichno color change
Hofmannno color change
Scottblue
Morrisblue precipitate

Pharmacology

Mechanism of action []

Lidocaine is a local anesthetic of the amide type. It is used to provide local anesthesia by nerve blockade at various sites in the body. It does so by stabilizing the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. In particular, the lidocaine agent acts on sodium ion channels located on the internal surface of nerve cell membranes. At these channels, neutral uncharged lidocaine molecules diffuse through neural sheaths into the axoplasm where they are subsequently ionized by joining with hydrogen ions. The resultant lidocaine cations are then capable of reversibly binding the sodium channels from the inside, keeping them locked in an open state that prevents nerve depolarization. As a result, with sufficient blockage, the membrane of the postsynaptic neuron will ultimately not depolarize and will thus fail to transmit an action potential. This facilitates an anesthetic effect by not merely preventing pain signals from propagating to the brain but by aborting their generation in the first place. In addition to blocking conduction in nerve axons in the peripheral nervous system, lidocaine has important effects on the central nervous system and cardiovascular system. After absorption, lidocaine may cause stimulation of the CNS followed by depression and in the cardiovascular system, it acts primarily on the myocardium where it may produce decreases in electrical excitability, conduction rate, and force of contraction. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

induction / metabolism / inhibition407 (46 contraindicated)
metabolism / induction / inhibition75 (17 contraindicated)
shared target44
shared target41
shared target41
shared target41
shared target41
shared target41
shared target41
shared target41
shared target41

Medical side effects []

131 side effects listed on drug labels in (lidocaine).

  • Nausea
  • Vomiting
  • Nervous system disorder
  • Cardiac arrest
  • Cardiac disorder
  • Acidosis
  • Anaphylactic shock
  • Anaphylactoid reaction
  • Angioedema
  • Aphonia
  • Apnoea
  • Arachnoiditis
  • Asthenia
  • Asthma
  • Back pain
  • Blister
  • Dermatitis bullous
  • Bronchospasm
  • Chest pain
  • Coma
  • Confusional state
  • Feeling abnormal
  • Contusion
  • Dysphagia
  • Dermatitis
  • Rash
  • Dermatitis contact
  • Diplopia
  • Dizziness
  • Lightheadedness
  • Somnolence
  • Dysarthria
  • Slurred speech
  • Osteoarthritis
  • Dysgeusia
  • Taste metallic
  • Dyspnoea
  • Oedema
  • Electric shock
  • Eye disorder
  • Flushing
  • Gastrointestinal disorder
  • Gingivitis
  • Headache
  • Atrioventricular block
  • Haemorrhage
  • Haemoglobin
  • Dysphonia
  • Hyperaesthesia
  • Hypersensitivity
  • Hypertension
  • Hypoaesthesia
  • Numbness
  • Hypotension
  • Immune system disorder
  • Laryngospasm
  • Meningism
  • Meningitis
  • Methaemoglobinaemia
  • Nervousness
  • Tension
  • Sensory loss
  • Obstruction
  • Paraesthesia
  • Petechiae
  • Pregnancy
  • Psychotic disorder
  • Hyperacusis
  • Respiratory paralysis
  • Rhinitis
  • Convulsion
  • Chills
  • Shock
  • Stomatitis
  • Mouth irritation
  • Tinnitus
  • Tremor
  • Loss of consciousness
  • Erythema
  • Redness
  • Urinary incontinence
  • Urticaria
  • Angiopathy
  • Ventricular fibrillation
  • Ventricular tachycardia
  • Urinary retention
  • Burning sensation
  • Agitation
  • Cranial nerve paralysis
  • Application site reaction
  • Depressed level of consciousness
  • Paraesthesia oral
  • Skin irritation
  • Nerve injury
  • Respiratory arrest
  • Leukoderma
  • Anterior spinal artery syndrome
  • Muscle twitching
  • Teratogenicity
  • Disorientation
  • Anxiety
  • Feeling hot
  • Tenderness
  • Neurological symptom
  • Respiratory depression
  • Pulmonary function test decreased
  • Euphoric mood
  • Sedation
  • Skin exfoliation
  • Oropharyngeal discomfort
  • Oropharyngeal pain
  • Peripheral nerve injury
  • Papule
  • Myocardial depression
  • Vision blurred
  • Cauda equina syndrome
  • Bradycardia
  • Neuropathy peripheral
  • Spinal anaesthesia
  • Hypoaesthesia oral
  • Hypoesthesia tongue
  • Application site irritation
  • Paralysis
  • Visual impairment
  • Hyperhidrosis
  • Local reaction
  • Pain
  • Vessel puncture site haemorrhage
  • Conjunctival hyperaemia
  • Endotracheal intubation complication
  • Neurotoxicity

Indications

  • Acute myocardial infarction
  • Arrhythmia
  • Circulatory depression
  • Discomfort
  • Excitability
  • Insect bite NOS
  • Oesophagitis
  • Pain
  • Sunburn
  • Urethritis
  • Ventricular arrhythmia

Subjective effects []

0xea / Lidocaine []
Routes:
  • Topical
Forms:
  • Freebase
Indication:
  • hemorrhoid
Effects:
  • numbing effect on rectum
emily / Lidocaine []
Routes:
  • Oral
Notes:
  • injection solution. helped numbing throat pain comparable to benzocaine

 []

  • Australia: Lidocaine is a S5, S4, and S2.[3]
  • Canada: Lidocaine is a OTC / Prescription only.[4][5]
  • United Kingdom: Lidocaine is a GSL, P, and Prescription only.[6]
  • United States: Lidocaine is a OTC / Prescription only.[7][8][9]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 3676, Lidocaine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3676
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lidocaine. UNII: 98PI200987. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/98PI200987
  3. Poisons Standard February 2021. Federal Register of Legislation. 1 January 2021. https://www.legislation.gov.au/Details/F2021C00098
  4. Xylocard Product information. Health Canada. 9 October 2018. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=4478
  5. Lidocaine Product information. Health Canada. 18 June 2015. https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83969
  6. Lidocaine Hydrochloride Injection BP 1% w/v - Summary of Product Characteristics (SmPC). (emc). 29 June 2020. https://www.medicines.org.uk/emc/product/6277/smpc
  7. Xylocaine MPF- lidocaine hydrochloride injection, solution Xylocaine- lidocaine hydrochloride injection, solution Xylocaine- lidocaine hydrochloride, epinephrine bitartrate injection, solution. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4dd52202-8eef-4136-92dd-ada573b7cf74
  8. Ztlido- lidocaine patch. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1b17507-4560-490d-a388-74e7fd7eaa5e
  9. 4% LIDOCAINE MAXIMUM STRENGTH PAIN RELIEF- lidocaine patch. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e5a5165-a773-0501-e063-6294a90ae2f4

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 10:58:32
drugsprook2026-11-20 10:58:28
erowidmissing (no Erowid substance of that name)2026-11-20 10:58:28
gsrsok2026-11-20 10:58:34
hmdbmissing (hmdb.ca refused automated access to HMDB0014426)2026-11-20 10:58:28
keggok2026-11-20 10:58:35
pubchemok2026-11-20 10:58:28
redditmissing (no r/tripreports posts mention it)2026-11-20 10:58:28
siderok2026-11-20 10:58:29
structureok2026-11-20 10:58:28
wikipediaok2026-11-20 10:58:29